ProCE Banner Activity

My Insights on the Latest Data on Tumor-Infiltrating Lymphocytes in Melanoma and Clinical Applications of TIL Therapy

Clinical Thought

Learn about the latest data on adoptive cellular technology using tumor-infiltrating lymphocytes (TILs) and how TIL therapy may fit into the current treatment paradigm for advanced melanoma.

Released: February 14, 2023

Begin Activity

Share

Faculty

Allison Betof Warner

Allison Betof Warner, MD, PhD

Assistant Member
Assistant Attending Physician
Melanoma Service
Division of Tumor Oncology
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

Iovance Biotherapeutics

Faculty Disclosure

Primary Author

Allison Betof Warner, MD, PhD

Assistant Member
Assistant Attending Physician
Melanoma Service
Division of Tumor Oncology
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

Allison Betof Warner, MD, PhD: consultant/advisor/speaker: Bristol-Myers Squibb, Instil Bio, Iovance, Lyell Immunopharma, Novartis, Pfizer, Shanghai Jo'Ann Medical Technology.